Skip to main content

Table 2 Predicted change from baseline in bladder diary variables after 12 weeks of treatment.

From: Modeling dose-response relationships of the effects of fesoterodine in patients with overactive bladder

 

Placebo

Fesoterodine 4 mg

Fesoterodine 8 mg

Micturitions per 24 hours

-1.2

-1.7

-2.2

UUI episodes per 24 hours

-1.1

-1.3

-1.4

MVV, mL

9.7

14.2*

28.4*

  1. MVV = mean voided volume; UUI = urgency urinary incontinence.
  2. *In addition to increase seen with placebo.
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us